TC
ANIP icon

Truvestments Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Truvestments Capital’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1K Hold
267
– – ﹤0.01% 668
2026
Q1 		$20.5K Hold
267
– – ﹤0.01% 637
2025
Q4 		$21.1K Hold
267
– – ﹤0.01% 582
2025
Q3 		$24.5K Hold
267
– – ﹤0.01% 556
2025
Q2 		$17.4K Hold
267
– – ﹤0.01% 556
2025
Q1 		$17.9K Hold
267
– – ﹤0.01% 573
2024
Q4 		$14.8K Hold
267
– – ﹤0.01% 539
2024
Q3 		$15.9K Buy
+267
New +$16.3K ﹤0.01% 521
2024
Q2 		– Sell
-267
Closed -$18.5K – 246
2024
Q1 		$18.5K Sell
267
-121
-31% -$7.3K 0.01% 444
2023
Q4 		$21.4K Hold
388
– – 0.01% 429
2023
Q3 		$22.5K Hold
388
– – 0.01% 373
2023
Q2 		$20.9K Buy
388
+121
+45% +$5.36K 0.01% 376
2023
Q1 		$10.6K Sell
267
-121
-31% -$5.1K 0.01% 433
2022
Q4 		$15.6K Hold
388
– – 0.01% 413
2022
Q3 		$12K Hold
388
– – 0.01% 387
2022
Q2 		$12K Buy
+388
New +$11.2K 0.01% 392
2022
Q1 		– Sell
-388
Closed -$18K – 202
2021
Q4 		$18K Hold
388
– – 0.01% 350
2021
Q3 		$13K Hold
388
– – 0.01% 350
2021
Q2 		$14K Hold
388
– – 0.01% 353
2021
Q1 		$14K Hold
388
– – 0.01% 406
2020
Q4 		$11K Buy
+388
New +$11.1K 0.01% 421
2020
Q3 		– Sell
-1,008
Closed -$32K – 334
2020
Q2 		$32K Sell
1,008
-564
-36% -$20.2K 0.03% 254
2020
Q1 		$64K Buy
+1,572
New +$83.6K 0.08% 155
2019
Q4 		– Sell
-2,261
Closed -$165K – 165
2019
Q3 		$165K Hold
2,261
– – 0.11% 143
2019
Q2 		$186K Buy
2,261
+281
+14% +$20K 0.13% 138
2019
Q1 		$140K Buy
+1,980
New +$116K 0.11% 134
2018
Q3 		$152K Buy
+2,686
New +$164K 0.07% 200

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Truvestments Capital's ANIP Position: Q2 2026 in Review

Truvestments Capital held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 267 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #668.

Truvestments Capital first reported a position in ANIP in Q3 2018 and has held it in 27 quarters since. The position peaked at $186K in Q2 2019. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Truvestments Capital held 267 shares of ANI Pharmaceuticals worth $22.1K as of Q2 2026.
  • Truvestments Capital left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #668 holding.
  • Truvestments Capital first reported a position in ANI Pharmaceuticals in Q3 2018 and has held it in 27 quarters since.
  • Truvestments Capital's ANI Pharmaceuticals position peaked at $186K in Q2 2019.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.